Drugs / GEM 231
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00004863 | Jul 1999 → Aug 2001 | cancer of unknown primary site | Montefiore Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT00004864 | Jul 1999 → Jun 2000 | cancer of unknown primary site | Montefiore Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GEM 231 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004863 ↗ |
| Route | Intravenous | “immediately followed by GEM 231 IV over 2 hours on days 1, 4, 8, and 11.” NCT00004864 ↗ |